Stromal cell-derived factor 1 decreases β-amyloid deposition in Alzheimer's disease mouse model
10.3760/cma.j.issn.0254-1424.2014.09.004
- VernacularTitle:基质细胞衍生因子1对阿尔茨海默病小鼠脑内Aβ的清除作用
- Author:
Qi WANG
;
Wei WANG
;
Dengji PAN
;
Zhou ZHU
;
Daiqi CHEN
- Publication Type:Journal Article
- Keywords:
Alzheimer's disease;
Beta amyloid;
Microglia;
Stromal cell derived factor-1;
Chemo-taxis
- From:
Chinese Journal of Physical Medicine and Rehabilitation
2014;36(9):671-675
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore whether stromal cell-derived factor 1 (SDF-1) can promote the clearance of β-amyloid deposition in the brain of APP/PS1 mice and the possible underlying mechanism.Methods Twelve 28-week-old APP/PS1 mice were divided into two groups:a treatment group and a control group.Animals were given the intracerebroventricular injection weekly with PBS or mouse recombinant SDF-1 α for eight weeks.Microglia and Aβ in cerebral cortex and hippocampal region of APP/PS1 mice were detected by immunofluorescence.Results After 8-week treatment,both the relative number and the relative area of Aβ deposits in the mice of treatment group were less than those in the control group.The relative number of plaque associated microglia increased to a significantly greater extent in the cortex and hippocampus in treatment group than those in the control group.Conclusion Injecting SDF-1α significantly reduced amyloid burden in APP/PS1 mice.This effect might associated with the improvement of the chemotoxis of microglia,which promote the phagocytosis of Aβ by microglia.